Combination treatment with VPA and MSCs‑TRAIL could increase anti‑tumor effects against intracranial glioma
Soon Park(MWT Materials (United States)), Sin‐Soo Jeun(The Catholic University of Korea Seoul St. Mary's Hospital)
Cited by 19
Related Papers
Valproic Acid Downregulates the Expression of MGMT and Sensitizes Temozolomide-Resistant Glioma Cells
|Journal of Biomedicine and Biotechnology|2012|114
Potential Application of Temozolomide in Mesenchymal Stem Cell-Based TRAIL Gene Therapy Against Malignant Glioma
|Stem Cells Translational Medicine|2014|55